Browsing Executive Prominent Alzheimer’s Disease: Genetics and Risk Factors by Author "b7308e32-cdd4-436e-b640-9d577735166c"

Now showing items 1-3 of 3

    • Codes and related files for generating the scores reported in "Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups" 

      Mukherjee, Shubhabrata (2018)

    • Genetic data and cognitively defined late-onset Alzheimer's disease subgroups 

      Mukherjee, Shubhabrata; Mez, Jesse; Trittschuh, Emily H.; Saykin, Andrew J.; Gibbons, Laura E.; Fardo, David W.; Wessels, Madeline; Bauman, Julianna; Moore, Mackenzie; Choi, Seo-Eun; Gross, Alden L.; Rich, Joanne; Louden, Diana Nelson; Sanders, R. Elizabeth; Grabowski, Thomas J.; Bird, Thomas D.; McCurry, Susan M.; Snitz, Beth E.; Kamboh, Ilyas; Lopez, Oscar L.; De Jager, Philip L.; Bennett, David A.; Keene, C. Dirk; Larson, Eric B.; EPAD Study Group; Investigators from ACT; Investigators from ROS; Investigators from MAP; Investigators from ADNI; Investigators from the University of Pittsburgh ADRC; Crane, Paul K. (Nature, 2018-12-04)
      Categorizing people with late-onset Alzheimer's disease into biologically coherent subgroups is important for personalized medicine. We evaluated data from five studies (total n = 4050, of whom 2431 had genome-wide ...

    • Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups 

      Mukherjee, Shubhabrata; Mez, Jesse; Trittschuh, Emily H.; Saykin, Andrew J.; Gibbons, Laura E.; Fardo, David W.; Wessels, Madeline; Bauman, Julianna; Moore, Mackenzie; Choi, Seo-Eun; Gross, Alden L.; Rich, Joanne; Louden, Diana Nelson; Sanders, R. Elizabeth; Grabowski, Thomas J.; Bird, Thomas D.; McCurry, Susan M.; Snitz, Beth E.; Kamboh, Ilyas; Lopez, Oscar L.; De Jager, Philip L.; Bennett, David A.; Keene, C. Dirk; Larson, Eric B.; EPAD Study Group; Investigators from ACT; Investigators from ROS; Investigators from MAP; Investigators from ADNI; Investigators from the University of Pittsburgh ADRC; Crane, Paul K. (Nature, 2018-12-04)
      Categorizing people with late-onset Alzheimer's disease into biologically coherent subgroups is important for personalized medicine. We evaluated data from five studies (total n = 4050, of whom 2431 had genome-wide ...